Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaana Oikkonen

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Plos One|March 6, 2013
Genome-wide copy number variation analysis in extended families and unrelated individuals characterized for musical aptitude and creativity in musicLiisa Ukkola-Vuoti, Chakravarthi Kanduri, Jaana Oikkonen, et al.
STAR Protocols|November 17, 2023
Quantification of cell death and proliferation of patient-derived ovarian cancer organoids through 3D imaging and image analysisAikaterini Skorda, Anna Røssberg Lauridsen, Kaisa Huhtinen, et al.
Translational Oncology|November 4, 2023
Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrenceGiovanni Marchi, Anna Rajavuori, Mai T N Nguyen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 16, 2022
QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variabilitySanaz Jamalzadeh, Antti Häkkinen, Noora Andersson, et al.
Science Advances|May 23, 2024
A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cellsDaria Bulanova, Yevhen Akimov, Wojciech Senkowski, et al.
BMC Cancer|February 5, 2024
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinomaSanaz Jamalzadeh, Jun Dai, Kari Lavikka, et al.
Gigascience|August 5, 2024
Deciphering cancer genomes with GenomeSpy: a grammar-based visualization toolkitKari Lavikka, Jaana Oikkonen, Yilin Li, et al.
Neoplasia (New York, N.Y.)|March 15, 2024
PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structuresHeidi Rausio, Alejandra Cervera, Vanina D Heuser, et al.
Gynecologic Oncology|December 7, 2023
HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinomaHeidi Koskela, Yilin Li, Titta Joutsiniemi, et al.
JCO Precision Oncology|September 11, 2020
Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian CancerJaana Oikkonen, Kaiyang Zhang, Liina Salminen, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Plos One|March 6, 2013
Genome-wide copy number variation analysis in extended families and unrelated individuals characterized for musical aptitude and creativity in musicLiisa Ukkola-Vuoti, Chakravarthi Kanduri, Jaana Oikkonen, et al.
STAR Protocols|November 17, 2023
Quantification of cell death and proliferation of patient-derived ovarian cancer organoids through 3D imaging and image analysisAikaterini Skorda, Anna Røssberg Lauridsen, Kaisa Huhtinen, et al.
Translational Oncology|November 4, 2023
Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrenceGiovanni Marchi, Anna Rajavuori, Mai T N Nguyen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 16, 2022
QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variabilitySanaz Jamalzadeh, Antti Häkkinen, Noora Andersson, et al.
Science Advances|May 23, 2024
A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cellsDaria Bulanova, Yevhen Akimov, Wojciech Senkowski, et al.
BMC Cancer|February 5, 2024
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinomaSanaz Jamalzadeh, Jun Dai, Kari Lavikka, et al.
Gigascience|August 5, 2024
Deciphering cancer genomes with GenomeSpy: a grammar-based visualization toolkitKari Lavikka, Jaana Oikkonen, Yilin Li, et al.
Neoplasia (New York, N.Y.)|March 15, 2024
PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structuresHeidi Rausio, Alejandra Cervera, Vanina D Heuser, et al.
Gynecologic Oncology|December 7, 2023
HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinomaHeidi Koskela, Yilin Li, Titta Joutsiniemi, et al.
JCO Precision Oncology|September 11, 2020
Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian CancerJaana Oikkonen, Kaiyang Zhang, Liina Salminen, et al.
Pageof 4